Relevance of high virulence Helicobacter pylori strains and futility of CDX2 expression for predicting intestinal metaplasia after eradication of infection

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 7-8, 2010, Pages 828-834

  Barros, Rita ^a   Peleteiro, Brbara ^a,b   Almeida, Raquel ^a,b   Figueiredo, Céu ^a,b   Barros, Henrique ^a,b   David, Leonor ^a,b   Lunet, Nuno ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

CDX2; chronic gastritis; gastric carcinoma; Helicobacter pylori; intestinal metaplasia

Indexed keywords

TRANSCRIPTION FACTOR CDX2;

ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DISEASE COURSE; ENDOSCOPY; ERADICATION THERAPY; FOLLOW UP; GENOTYPE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; INFECTION CONTROL; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRULENCE;

ADULT; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOMEODOMAIN PROTEINS; HUMANS; INTESTINES; MALE; METAPLASIA; MIDDLE AGED;

EID: 77955694652     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521003770269     Document Type: Article

References (30)

1. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007;133:659-672
2. Schistosomes, Liver flukes and Helicobacter pylori. IARC Working group on the Evaluation of Carcionogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
3. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-3044
4. Correa P, HaenszelW,CuelloC,TannenbaumS, ArcherM.A model for gastric cancer epidemiology. Lancet 1975;2:58-60.
5. Figueiredo C, Van Doorn LJ, Nogueira C, Soares JM, Pinho C, Figueira P, et al. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol 2001;36:128-135
6. Peleteiro B, Lunet N, Figueiredo C, Carneiro F, David L, Barros H. Smoking, Helicobacter pylori virulence, and type of intestinal metaplasia in Portuguese males. Cancer Epidemiol Biomarkers Prev 2007;16:322-326
7. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002;94:1680-1687
8. Asfeldt AM, Steigen SE, Løchen ML, Straume B, Johnsen R, Bernersen B, et al. The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the Sørreisa gastrointestinal disorder study. Eur J Epidemiol 2009;24:649-658
9. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China. A randomized controlled trial. JAMA 2004;291:187-194
10. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000;92:1881-1888
11. Zhou L, Sung JJ, Lin S, Jin Z, Ding S, Huang X, et al. A fiveyear follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chin Med J (Engl) 2003;116:11-14
12. Ley C, Mohar A, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, et al. Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, doubleblind, placebo-controlled trial. Cancer Epidemiol Biomarkers Prev 2004;13:4-10.
13. Cai X, Carlson J, Stoicov C, Li H, Wang TC, Houghton J. Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology 2005;128:1937-1952
14. Mesquita P, Raquel A, Nuno L, Reis CA, Silva LF, Serpa J, et al. Metaplasia-a transdifferentiation process that facilitates cancer development: the model of gastric intestinal metaplasia. Crit Rev Oncog 2006;12:3-26.
15. Guo RJ, Suh ER, Lynch JP. The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther 2004;3:593-601.
16. Almeida R, Silva E, Santos-Silva F, Silberg DG, Wang J, De Bolós C, et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol 2003;199:36-40.
17. Silberg DG, Sullivan J, Kang E, Swain GP, Moffett J, Sund NJ, et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 2002;122:689-696
18. Vauhkonen M, Vauhkonen H, Sipponen P. Helicobacter pylori infection induces a reversible expression of the CDX2 transcription factor protein in human gastric epithelium. Scand J Gastroenterol 2008; 43:915-921
19. Satoh K, Mutoh H, Eda A, Yanaka I, Osawa H, Honda S, et al. Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori. Helicobacter 2002;7:192-198
20. Barros R, Marcos N, Reis CA, De Luca A, David L, Almeida R. CDX2 expression is induced by Helicobacter pylori in AGS cells. Scand J Gastroenterol 2009;44:124-125
21. Lunet N, Pina F, Barros H. Regional trends in Portuguese gastric cancer mortality (1984-1999). Eur J Cancer Prev 2004;13:271-275
22. Current European concepts in the management of Helicobacter pylori infecton. The Maastricht Consensus Report. European Helicobacter pylori Study Group. Gut 1997;41: 8-13.
23. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 1996;20:1161-1181.
24. Reis CA, David L, Correa P, Carneiro F, de Bolós C, Garcia E, et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2,MUC5AC, and MUC6) expression. Cancer Res 1999;59:1003-1007
25. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503.
26. van van Doorn LJ, Figueiredo C, Sanna R, Pena S, Midolo P, Ng EK, et al. Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol 1998;36:2597-2603
27. Braden B. Methods and functions: Breath tests. Best Pract Res Clin Gastroenterol 2009;23:337-352
28. Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J Gastroenterol Hepatol 2009;24:193-201.
29. Machado AM, Figueiredo C, Touati E, Máximo V, Sousa S, Michel V, et al. Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clin Cancer Res 2009;15:2995-3002.
30. Eda A, Osawa H, Satoh K, Yanaka I, Kihira K, Ishino Y, et al. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J Gastroenterol 2003;38:14-22.